Compare NNNN & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | TRS |
|---|---|---|
| Founded | 2021 | 1986 |
| Country | Germany | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | 2004 |
| Metric | NNNN | TRS |
|---|---|---|
| Price | $25.50 | $42.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.50 |
| AVG Volume (30 Days) | 12.8K | ★ 391.9K |
| Earning Date | 04-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | N/A | ★ 400.00 |
| EPS | N/A | ★ 21.40 |
| Revenue | N/A | ★ $645,720,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | N/A | $4.27 |
| P/E Ratio | $446.57 | ★ $1.96 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.03 | $24.56 |
| 52 Week High | $55.65 | $42.48 |
| Indicator | NNNN | TRS |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 72.69 |
| Support Level | $26.31 | $33.53 |
| Resistance Level | $30.21 | N/A |
| Average True Range (ATR) | 2.10 | 1.63 |
| MACD | -0.28 | 0.59 |
| Stochastic Oscillator | 20.78 | 92.17 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
TriMas Corp designs, develops and manufactures a diverse set of products for the consumer products, and industrial markets . The company operates through two segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners. The packaging segment generates majority of its revenue.